AI Safety Training Can be Clinically Harmful

Most AI mental health chatbots lack clinical testing: Only 16% of LLM-based mental health chatbots have undergone rigorous clinical efficacy testing, yet simulations show psychological deterioration in over one-third of cases, raising serious questions about deployment at scale without proper validation.

AI safety training creates a dangerous paradox: The very safety measures designed to protect users (like refusing to engage with self-harm content) actually undermine evidence-based therapies like Prolonged Exposure and Cognitive Behavioral Therapy, causing models to abandon therapeutic protocols or offer false reassurance when patients need to confront difficult thoughts.

Performance collapses under realistic conditions: While AI models appear competent at surface-level responses (91-100% accuracy), their therapeutic appropriateness drops dramatically to 22-33% when handling severe cases, and protocol fidelity reaches zero for two of four models tested—meaning they fail to follow established clinical guidelines.

Current AI evaluation methods are insufficient: Standard AI safety metrics don't capture whether a system is actually helping or harming patients; the authors propose a new five-axis framework (protocol fidelity, hallucination risk, behavioral consistency, crisis safety, demographic robustness) aligned with FDA and EU regulatory requirements.

Responsible deployment requires clinical expertise, not just AI expertise: Developing safe AI mental health tools demands collaboration between AI researchers and clinical psychologists to ensure safety measures don't sabotage therapeutic effectiveness—a gap that currently exists in most AI development.